Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience
Meningococcal diseases are serious threats to global health, and new vaccines specifically tailored to meet the age-related needs of various geographical areas are required. This paper focuses on the meningococcal conjugate vaccines developed by GSK Biologicals. Two combined conjugate vaccines were...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
2011-01-01
|
| Series: | Advances in Preventive Medicine |
| Online Access: | http://dx.doi.org/10.4061/2011/846756 |